Status:

RECRUITING

Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis

Lead Sponsor:

Centre Hospitalier Universitaire Dijon

Conditions:

Cirrhosis

Eligibility:

All Genders

18+ years

Brief Summary

Fasting blood glucose is maintained by hepatic production of glucose from glycogenolysis or gluconeogenesis. In cirrhosis, glycogen storage capacity is reduced, with a consequent increase in gluconeog...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age ≥18 years
  • Person with oral consent
  • Patient with cirrhosis according to the 2021 EASL criteria (1)
  • Patient receiving regular six-monthly and systematic monitoring of cirrhosis, according to the European recommendations of the EASL (2), or French recommendations of the TNCD (3) and HAS (4), including a clinical examination, a biological work-up (to calculate the CHILD-PUGH score and monitor alpha-feto-protein), AND requiring imaging to screen for HCC of hepatocellular carcinoma using cross-sectional imaging (by MRI and/or hepatic CT scan).
  • Exclusion Criteria:
  • Patients with active cancer or treated within the last 6 months
  • Patient with an acute episode of cirrhosis decompensation (ongoing antibiotic treatment for an active infection, gastrointestinal bleeding, hepatic encephalopathy, acute alcoholic hepatitis) less than one month old.
  • Treatment with systemic corticosteroids, in progress or within the last 3 months
  • Patient with organ transplant
  • Person not affiliated to or not benefiting from a social security scheme
  • Person under legal protection (curatorship, guardianship)
  • Person subject to a legal protection measure
  • Pregnant or breast-feeding women
  • An adult who is incapable or unable to give consent
  • Minors
  • Patients already included in an interventional study who may interfere with the evaluation of this study.

Exclusion

    Key Trial Info

    Start Date :

    September 9 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2027

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT06948656

    Start Date

    September 9 2025

    End Date

    October 1 2027

    Last Update

    September 16 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHU Dijon Bourgogne

    Dijon, France, 21000